Effect of maximum inhalation flow and inhaled volume on formoterol drug deposition in-vitro from an Easyhaler® dry powder inhaler

被引:20
作者
Abadelah, Mohamad [1 ]
Hazim, Firisteh [1 ]
Chrystyn, Henry [3 ]
Bagherisadeghi, Golshan [1 ]
Rahmoune, Hassan [2 ]
Larhrib, Hassan [1 ]
机构
[1] Univ Huddersfield, Dept Pharm & Pharmaceut Sci, Huddersfield HD1 3DH, W Yorkshire, England
[2] Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge CB2 3RA, England
[3] Inhalat Consultancy Ltd, Leeds LS19 7SP, W Yorkshire, England
基金
英国工程与自然科学研究理事会;
关键词
Andersen Cascade impactor; Easyhaler; Formoterol; Inhaled volume; Maximum inhalation flow; LUNG DEPOSITION; CASCADE IMPACTOR; PARTICLE-SIZE; DEVICE DESIGN; PERFORMANCE; ASTHMA; COPD; AEROSOLIZATION; BUDESONIDE; SALBUTAMOL;
D O I
10.1016/j.ejps.2017.03.035
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Most patients using dry powder inhalers (DPIs) do not achieve the inhalation parameters recommended for pharmacopoeial in-vitro dose emission testing. The dose emission characteristics of formoterol from an Easyhaler((R)) have been measured using the Andersen Cascade Impactor (ACI) with a maximum inhalation flow (MIF) of 28.3, 60 and 90 L/min and inhaled volumes (Vin) of 240, 750, 1500 and 2000 mL. The total emitted dose (TED) was significantly higher at 90 L/min (p < 0.05), but the difference in the TED between low (28.3 L/min) and high (90 L/min) flow rate was significantly reduced by increasing the Vin. The fine particle dose (FPD) was higher (p < 0.05) at 90 L/min for all Vin values compared to 28.3 and 60 L/min. Similarly the mass median aerodynamic diameter (MMAD) was smaller at 90 L/min across all Vin values. Dose emission characteristics were lower at 240 mL for both 1VIIFs. The results for 240 mL could be due to an insufficient Vin pulled through the ACI or incomplete emptying of the dose metering cup. This study shows that the FPD, %FPF and MMAD were not significantly affected by the vin >= 750 mL and that an inhaled volume as low as 750 mL could be used with the ACI.
引用
收藏
页码:180 / 187
页数:8
相关论文
共 31 条
[1]   Emitted dose and lung deposition of inhaled terbutaline from Turbuhaler at different conditions [J].
Abdelrahim, Mohamed E. .
RESPIRATORY MEDICINE, 2010, 104 (05) :682-689
[2]   The Inhalation Characteristics of Patients When They Use Different Dry Powder Inhalers [J].
Azouz, Wahida ;
Chetcuti, Philip ;
Hosker, Harold S. R. ;
Saralaya, Dinesh ;
Stephenson, John ;
Chrystyn, Henry .
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2015, 28 (01) :35-42
[3]   Clarifying the dilemmas about inhalation techniques for dry powder inhalers: integrating science with clinical practice [J].
Azouz, Wahida ;
Chrystyn, Henry .
PRIMARY CARE RESPIRATORY JOURNAL, 2012, 21 (02) :208-213
[4]   Inhalation profiles in asthmatics and COPD patients: Reproducibility and effect of instruction [J].
Broeders, MEAC ;
Molema, J ;
Hop, WCJ ;
Folgering, HTM .
JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG, 2003, 16 (02) :131-141
[5]   Effect of Flow Rate on In Vitro Aerodynamic Performance of NEXThaler® in Comparison with Diskus® and Turbohaler® Dry Powder Inhalers [J].
Buttini, Francesca ;
Brambilla, Gaetano ;
Copelli, Diego ;
Sisti, Viviana ;
Balducci, Anna Giulia ;
Bettini, Ruggero ;
Pasquali, Irene .
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2016, 29 (02) :167-178
[6]   The Genuair® inhaler: a novel, multidose dry powder inhaler [J].
Chrystyn, H. ;
Niederlaender, C. .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2012, 66 (03) :309-317
[7]   Is inhalation rate important for a dry powder inhaler? using the In-Check Dial to identify these rates [J].
Chrystyn, H .
RESPIRATORY MEDICINE, 2003, 97 (02) :181-187
[8]  
Chrystyn H., 2009, RESP DRUG DELIV EUR, P1
[9]   Effect of inhalation profile and throat geometry on predicted lung deposition of budesonide and formoterol (BF) in COPD: An in-vitro comparison of Spiromax with Turbuhaler [J].
Chrystyn, Henry ;
Safioti, Guilherme ;
Keegstra, Johan Rene ;
Gopalan, Gokul .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2015, 491 (1-2) :268-276
[10]   THE RELATIONSHIP BETWEEN POWDER INHALER RESISTANCE AND PEAK INSPIRATORY CONDITIONS IN HEALTHY-VOLUNTEERS - IMPLICATIONS FOR IN-VITRO TESTING [J].
CLARK, AR ;
HOLLINGWORTH, AM .
JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG, 1993, 6 (02) :99-110